Search Share Prices
AZN Share Price - Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC
StockMarketWire.com - Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 7800p (from 7600p).
AstraZeneca’s Lynparza meets primary endpoint in late-stage ovarian cancer trial
AstraZeneca is competing with GSK to win the race to become the go-to maintenance treatment for people who have been treated for ovarian cancer Lynparza has already been approved as a maintenance ...
FTSE 100 closes at five month low as recession fears loom large
AstraZeneca (LON:AZN) rose a further 2% as its re-rating continued in the wake of better than expected trading and series of new drug successes. Balfour Beatty (LON:BBY) enjoyed a results-driven ...
Broker Forecast - UBS issues a broker note on AstraZeneca PLC
StockMarketWire.com - UBS today reaffirms its sell investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 5700p (from 5400p).
FTSE 100 sinks further; UK inflation unexpectedly jumps above 2%
AstraZeneca (LON:AZN) rose a further 2% as its re-rating continued in the wake of better than expected trading and series of new drug successes. Balfour Beatty (LON:BBY) enjoyed a results-driven ...